Novacta Biosystems Limited
Patent Applications and Registrations
Patent applications and USPTO patent grants for Novacta Biosystems Limited.The latest application filed is for "compounds".
- Novacta Biosystems Limited - Hertfordshire N/A GB
- NOVACTA BIOSYSTEMS LIMITED - Welwyn Garden City GB
- Novacta Biosystems Limited - Hartfield GB
| Patent | Date |
|---|---|
| Compounds Grant 9,234,006 - Saadi , et al. January 12, 2 | 2016-01-12 |
| Formulations for infusion of type B lantibiotics Grant 9,192,569 - Appleyard , et al. November 24, 2 | 2015-11-24 |
| Actagardine derivatives, and pharmaceutical use thereof Grant 9,006,392 - Dawson , et al. April 14, 2 | 2015-04-14 |
| Compounds App 20150031602 - Saadi; Mona ; et al. | 2015-01-29 |
| Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae Grant RE45,003 - Boakes , et al. July 8, 2 | 2014-07-08 |
| Compounds Grant 8,741,945 - Wadman June 3, 2 | 2014-06-03 |
| Compounds Grant 8,729,031 - Wadman May 20, 2 | 2014-05-20 |
| Use of type-B lantibiotic-based compounds having antimicrobial activity Grant 8,575,094 - Wadman , et al. November 5, 2 | 2013-11-05 |
| Formulation Comprising a Type B Lantibiotic App 20130171252 - Appleyard; Antony Nicholas ; et al. | 2013-07-04 |
| Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae Grant 8,465,947 - Boakes , et al. June 18, 2 | 2013-06-18 |
| Formulations For Infusion Of Type B Lantibiotics App 20130137630 - Appleyard; Antony Nicholas ; et al. | 2013-05-30 |
| Lantibiotic-based compounds having antimicrobial activity Grant 8,329,644 - Wadman December 11, 2 | 2012-12-11 |
| Compounds Grant 8,283,371 - Wadman October 9, 2 | 2012-10-09 |
| Lantibiotic Biosynthetic Gene Clusters From A. Garbadinensis And A. Liguriae App 20110306091 - Boakes; Steven ; et al. | 2011-12-15 |
| Compounds App 20110294723 - Wadman; Sjoerd Nicolaas | 2011-12-01 |
| Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. Liguriae Grant 7,989,416 - Boakes , et al. August 2, 2 | 2011-08-02 |
| Compounds App 20100179207 - Wadman; Sjoerd Nicolaas | 2010-07-15 |
| F3W variants of the lantibiotic mersacidin and its use Grant 7,592,308 - Dawson , et al. September 22, 2 | 2009-09-22 |
| Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity App 20090203583 - Wadman; Sjoerd Nicolaas ; et al. | 2009-08-13 |
| Production of mersacidin and its variants in SigH and/or mrsA negative bacillus host cells App 20070117749 - Dawson; Michael John ; et al. | 2007-05-24 |
| CAGE Code | U0CV9 | NOVACTA BIOSYSTEMS LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 